IDEAYA Biosciences, Inc.
IDYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,099,125 | $2,046,559 | $753,050 | $833,368 |
| - Cash | $84,378 | $157,018 | $68,632 | $92,046 |
| + Debt | $19,171 | $2,872 | $3,482 | $5,181 |
| Enterprise Value | $2,033,918 | $1,892,413 | $687,900 | $746,503 |
| Revenue | $7,000 | $23,385 | $50,931 | $27,941 |
| % Growth | -70.1% | -54.1% | 82.3% | – |
| Gross Profit | $3,166 | $19,377 | $48,830 | $26,216 |
| % Margin | 45.2% | 82.9% | 95.9% | 93.8% |
| EBITDA | -$270,643 | -$108,953 | -$56,554 | -$48,037 |
| % Margin | -3,866.3% | -465.9% | -111% | -171.9% |
| Net Income | -$274,477 | -$112,961 | -$58,655 | -$49,762 |
| % Margin | -3,921.1% | -483% | -115.2% | -178.1% |
| EPS Diluted | -3.36 | -1.96 | -1.42 | -1.41 |
| % Growth | -71.4% | -38% | -0.7% | – |
| Operating Cash Flow | -$247,584 | -$115,224 | -$87,175 | -$55,779 |
| Capital Expenditures | -$3,857 | -$2,368 | -$3,443 | -$2,644 |
| Free Cash Flow | -$251,441 | -$117,592 | -$90,618 | -$58,423 |